FMI addendum re patient care: Any cancer patient or caretaker who understands how FMI operates should continue to opt for one the company’s flagship products: FoundationOne (for solid cancers) and FoundationOne Heme (for hematological malignancies).
Although FoundationOne and FoundationOne Heme may not be covered by a given patient’s heath insurance, as a matter of policy FMI does not pursue unpaid bills from patients.
p.s. I’m still waiting for an answer to the quiz in #msg-136558104.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.